|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52872035
???header.onlineuser??? :
708
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"wang"???jsp.browse.items-by-author.description???
Showing items 236-245 of 3269 (327 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-09 |
The risk of free flap revision and subsequent medical costs in patients with hypopharyngeal cancer
|
Ho;Chun-Hsien;Luo;Sheng-Dean;Chen;Wei-Chih;Chiu;Tai-Jan;Wang;Yu-Ming;Wu;Shao-Chun;Yang;Yao-Hsu;Li;Shau-Hsuan;Kuo;Spencer, Chia-Hao;Wu;Ching-Nung |
| 國立成功大學 |
2024-09 |
Establishing a biomonitoring baseline by characterizing the hair metabolome across age and sex using high-resolution mass spectrometry
|
Chang;Chih-Wei;Wu;Chih-Hsing;Wang;Ru-Hsueh;Lo;Yu-Tai;Liao;Pao-Chi |
| 國立成功大學 |
2024-09 |
Fibromyalgia as a Potential Initial Presentation for Autoimmune Conditions
|
Wang;Qi;Chaudhary;Pratibha;Chang;Yu;Garg;Megha |
| 國立成功大學 |
2024-09 |
Clinimetric Properties of the FIND-NEEDS to Screen Geriatric Conditions
|
Chang;Chia-Ming;Lin;Chung-Ying;-Hu;Fang-Wen;Wang;Ying-Wei;Huang;Chi-Chang;Lo;Yu-Tai;Wu;Chien-Yuan;Chung;Yuan-Fang;Kang;Chiu-Chen;Chen;Yi-Jung;Yang;Yi-Ching;Liu;Li-Fan;Griffiths;Mark, D.;Lin;Dai-Chan;Shen;Meng-Ru |
| 國立成功大學 |
2024-09 |
Integrating technical indicators, chip factors and stock news for enhanced stock price predictions: A multi-kernel approach
|
Wang;Hei-Chia;Hsiao;Wei-Ching;Liou;Ru-Siang |
| 國立成功大學 |
2024-09 |
Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin
|
Chen;Shih-Yao;Wang;Chung-Teng;Huang;Tang-Hsiu;Tsai;Jeng-Liang;Wang;Hao-Tien;Yen;Yi-Ting;Tseng;Yau-Lin;Wu;Chao-Liang;Chang;Jia-Ming;Shiau;Ai-Li |
| 國立成功大學 |
2024-09 |
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer
|
Su;Y-Y;Bai;L-Y;Huang;C-J;Chiu;C-F;Wang;H-T;Du;J-S;Wang;H-C;Chuang;S;Shih;Y-H;Lin;H-C;Shan;Y-S;Chen;L-T |
| 國立成功大學 |
2024-09 |
Initial results from a first-in-human study of AZD5335, a folate receptor a (FRa)-targeted antibody-drug conjugate, in patients (pts) with platinum-resistant recurrent ovarian cancer (PRROC)
|
Shapira-Frommer;R;Sudo;K;Harano;K;Mileshkin;L;Perets;R;Song;M;Cohen;J;Huang;Y-F;Ambrose;H;Brier;T;Dosani;A;Fraenkel;P, G.;Kmieciak;A;Mitchell;P;Myers;C;Wang;J;Odegbami;R, I.;Sykes;A;Turner;S;Meric-Bernstam;F |
| 國立成功大學 |
2024-09 |
Adverse outcome pathway-based approach to reveal the mechanisms of skin sensitization and long- term aging effects of chlorothalonil
|
Wang;Y-J;Cheng;Y-H;Wu;H-I;Chen;Y-Y;Lee;Y-H;Wang;B-J |
| 國立成功大學 |
2024-09 |
Phase I/Ib open-label study of an HER2-targeted T cell engager (TCE)-SAR443216 in patients (pts) with advanced solid tumors: Intravenous (IV) dose-escalation results
|
Garcia, Moreno;V;Oh;D-Y;Ryu;M, H.;Calvo;E;Garralda;E;Chung;W-P;Bai;L-Y;Laimito, Rojas;K, I.;Yildirim;O;Masciari;S;Mi;G;Wang;L;Kanlikilicer;P;Buday;B;Rharbaoui;F;Abbadessa;G;Dumbrava;E, E. E. |
Showing items 236-245 of 3269 (327 Page(s) Totally)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
View [10|25|50] records per page
|
